Maxim Frizler

557 citations
18 papers · 466 indexed · h-index 11
Topics
Protease and Inhibitor Mechanisms (11 papers)Peptidase Inhibition and Analysis (10 papers)Chemical Synthesis and Analysis (3 papers)
Partner nations
GermanyAustraliaSpain

In The Last Decade

Maxim Frizler

18 papers receiving 461 citations

Peers

Maxim Frizler
Comparison fields: 5 of 58
  • Molecular Biology 278
  • Organic Chemistry 155
  • Cancer Research 151
  • Oncology 128
  • Pharmacology 41
Replace Peter J. Coles with:
Peter J. Coles Canada
Estelle G. McLean United Kingdom
Keiji Hemmi Japan
Liyun Ji China
Weiqiang Zhan China
Carlo Gallina Italy
Laxman Nallan United States
Christophe Mellon Canada
Christopher P. Borella United States
S. Lovell United States
Maxim Frizler relative to Peter J. Coles Canada Peter J. Coles's profile →
Citations per field
00.5×10×20×30×35×
Peter J. Coles · 1×
Citations per year

Countries citing papers authored by Maxim Frizler

Since Specialization
Citations

This map shows the geographic impact of Maxim Frizler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim Frizler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim Frizler more than expected).

Fields of papers citing papers by Maxim Frizler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxim Frizler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim Frizler. The network helps show where Maxim Frizler may publish in the future.

Co-authorship network of co-authors of Maxim Frizler

This figure shows the co-authorship network connecting the top 25 collaborators of Maxim Frizler. A scholar is included among the top collaborators of Maxim Frizler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxim Frizler. Maxim Frizler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 10
2 5
3 26
4 22
5 32
6 15
7 15
8 48
9 13
10 93
11 71
12 14
13 2
14 6
15 8
16 75
17 10
18 1

About Maxim Frizler

Maxim Frizler is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 18 papers that have together received 466 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (11 papers), Peptidase Inhibition and Analysis (10 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Cancer Research (151 citations), Organic Chemistry (155 citations) and Oncology (128 citations). Maxim Frizler has collaborated with scholars based in Germany, Australia and Spain. Frequent co-authors include Michael Gütschow, Friederike Lohr, Reik Löser, Marit Stirnberg, Mihiret T. Sisay, Klaus Schilling, Norbert Furtmann, Михаил С. Баранов, Ilia V. Yampolsky and Marc Sylvester. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Chemistry - A European Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026